Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEli Lilly and Company Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 11 | $2.77 | $3.99 | $3.26 |
| Q2 2025 | 19 | $5.28 | $5.93 | $5.60 |
| Q3 2025 | 13 | $5.35 | $6.82 | $5.69 |
| Q4 2025 | 12 | $6.68 | $8.32 | $7.15 |
| Q1 2026 | 5 | $6.29 | $8.86 | $7.54 |
| Q2 2026 | 1 | $7.53 | $8.74 | $7.94 |
| Q3 2026 | 1 | $8.03 | $9.32 | $8.47 |
| Q4 2026 | 1 | $8.48 | $9.85 | $8.95 |
Eli Lilly and Company Earnings Date And Information
Eli Lilly and Company last posted its earnings results on Thursday, October 30th, 2025. The company reported $7.02 earnings per share for the quarter, topping analysts' consensus estimates of $5.69 by $1.33. The company had revenue of 17.60 B for the quarter and had revenue of 45.04 B for the year. Eli Lilly and Company has generated $12 earnings per share over the last year ($11.71 diluted earnings per share) and currently has a price-to-earnings ratio of 48.6. Eli Lilly and Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based on prior year's report dates.
Eli Lilly and Company Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2025 | Q3 2025 | $5.69 | $6.22 | 0.53 | $16.05 B | $17.60 B |
| 08/07/2025 | Q2 2025 | $5.60 | $6.30 | 0.7 | $14.70 B | $15.56 B |
| 05/01/2025 | Q1 2025 | $3.26 | $3.07 | -0.19 | N/A | $12.73 B |
| 02/19/2025 | Q4 2024 | N/A | $4.91 | N/A | N/A | $13.53 B |
| 10/30/2024 | Q3 2024 | $1.47 | $1.08 | -0.39 | $12.10 B | $11.44 B |
| 08/08/2024 | Q2 2024 | $2.60 | $3.29 | 0.69 | $9.98 B | $11.30 B |
| 04/30/2024 | Q1 2024 | $2.46 | $2.49 | 0.03 | N/A | $8.77 B |
| 02/21/2024 | Q4 2023 | N/A | $2.43 | N/A | N/A | $9.35 B |
| 11/02/2023 | Q3 2023 | -$0.08 | -$0.06 | 0.02 | $8.97 B | $9.50 B |
| 08/08/2023 | Q2 2023 | $1.98 | $1.86 | -0.12 | $7.58 B | $8.31 B |
| 04/27/2023 | Q1 2023 | $1.73 | $1.42 | -0.31 | $6.86 B | $6.96 B |
| 02/22/2023 | Q4 2022 | N/A | $2.04 | N/A | $7.33 B | $7.30 B |
| 11/01/2022 | Q3 2022 | $1.92 | $1.61 | -0.31 | $6.89 B | $6.94 B |
| 08/04/2022 | Q2 2022 | $1.69 | $1.06 | -0.63 | $6.85 B | $6.49 B |
| 04/29/2022 | Q1 2022 | N/A | $2.00 | N/A | $7.29 B | $7.81 B |
| 02/23/2022 | Q4 2021 | N/A | $1.81 | N/A | $7.69 B | $8.00 B |
| 10/27/2021 | Q3 2021 | N/A | $1.16 | N/A | $6.64 B | $6.77 B |
| 08/03/2021 | Q2 2021 | $1.89 | $1.53 | -0.36 | $6.60 B | $6.74 B |
| 04/30/2021 | Q1 2021 | N/A | $1.41 | N/A | $6.93 B | $6.81 B |
| 02/17/2021 | Q4 2020 | N/A | $2.21 | N/A | $7.27 B | $7.44 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Eli Lilly and Company Earnings: FAQ's
Eli Lilly and Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based offlast year's report dates.
In the previous quarter, Eli Lilly and Company (:LLY) reported $7.02 earnings per share (EPS) to beat the analysts' consensus estimate of $5.69 by $1.33.
The conference call for Eli Lilly and Company's latest earnings report can be listened to online.
The conference call transcript for Eli Lilly and Company's latest earnings report can be read online.
Eli Lilly and Company (:LLY) has a recorded annual revenue of $45.04 B.
Eli Lilly and Company (:LLY) has a recorded net income of $10.59 B.Eli Lilly and Company has generated $11.76 earnings per share over the last four quarters.
Eli Lilly and Company (:LLY) has a price-to-earnings ratio of 48.6 and price/earnings-to-growth ratio is 1.45.